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Introduction
Proteins have been proven to be among the most significant cellular molecules as they participate
in most cellular functionalities. Researchers have deployed a variety of experimental methods
for the identification of Protein–Protein Interactions (PPIs). The emergence of high-throughput
experimental techniques for the prediction of PPIs, revealed a wide range of PPIs in many
organisms. This information alongside with information from small scale experimental techniques
has been stored in public available databases and repositories. It is well-known that experimental
data includemany false positive predictions and provide only low coverage on the full interactomes.
This fact has led to the design and development of many computational methods for the prediction
of PPIs (Theofilatos et al., 2011).
The experimental PPI data have been extensively used in many studies during the last decades
and their availability gave a significant boost in training new algorithmic models for the prediction
of PPIs and in the overall analysis of PPI data.
Despite the promising results of algorithmic solutions for PPIs’ analysis which fostered
molecular biology research, in our opinion the research on computational methods for analyzing
PPI data has been recently stagnated. Using the online tool MLtrends introduced by Palidwor and
Andrade-Navarro (2010) in a preliminary investigation we have observed that the publications
related to the search term “protein–protein interactions” AND analysis (abstract and title were
searched for this term) present a constant increase in absolute numbers. However, when applying
normalization by dividing with the total number of annual publications, we observe a relatively
stable percentage of publications related PPI analysis in the last decade. In contrast, systems biology
publications present a big positive slope in the last decade even when normalized by the total
number of annual publications. This diversification shows that even if the actual total number
of publications related to PPIs analysis is increasing as the total number of scientific journals
is increasing in the last decade, their total impact on the systems biology domain is decreasing.
Additionally, only a few PPI based research works have been published lately with significant
impact in clinical research and translational bioinformatics.
In this paper, first we summarize the developments on computational analysis of PPI data and
second, we present our belief about the future of PPI data analysis emphasizing in presenting
the constraints that have delayed the transition from the current methodologies to a holistic
bioinformatics approach, for linking biological and clinical data. Specific solutions are also
1Latin phrase meaning ′′Where are you going?
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proposed for all these constraints in order to achieve the optimal
exploitation of PPI bioinformatics’ approaches.
State-of-the-art and Recent Advancements
of the Computational Analysis of PPI Data
A wide range of computational methodologies and tools have
been proposed during the last decade for the analysis of PPI data.
These methods are emphasizing on algorithmic solutions for the
problems of predicting and scoring PPIs, the construction of PPI
networks, the prediction of protein complexes, and the functional
annotation of proteins. The results of these solutions have been
uploaded to public available databases and many tools have
been supplied to the molecular research scientific community
enabling the analysis of the PPIs from a single organism in
a few days. State of the art computational methods for the
prediction of PPI combine information from different sources
and have presented adequate classification performance. Recent
approaches (Zhang et al., 2012; Saha et al., 2014; Theofilatos
et al., 2014) have attempted to overcome the bottlenecks in
this PPIs prediction, namely the definition of negative datasets,
the feature selection, the class imbalance, the tradeoff between
classification performance and interpretability, missing features
values and the calculation of a confidence score for every PPI.
The advancements on the computational prediction and scoring
of PPI enabled the construction of binary PPI networks with
increased coverage on the full interactome. Many tools have been
developed so far offering efficient and interactive visualization
of large PPI networks (Smoot et al., 2011; Li et al., 2013;
Tripathi et al., 2014). As a next step, significant results have been
extracted from the analysis of PPI graphs. This analysis includes
methods for predicting protein complexes (Chen et al., 2014)
and the functional and topological characterization of proteins
(Ma et al., 2014). Recent approaches (Nepusz et al., 2012; Hanna
and Zaki, 2014; Theofilatos et al., 2015) have attempted to face
with some of the remaining challenges for the prediction of
protein complexes such as the prediction of overlapping clusters
and the management of weighted PPI graphs thus increasing
the accuracy having limited prior knowledge for known protein
complexes. One of the ultimate goals of PPI data analysis is
to functionally characterize proteins and their interactions. The
main limitation of protein function prediction until now is
that a combined framework to characterize the full proteome
functionally of a single organism having a meaningful confidence
score for every annotation does not exist. However, with the
continued development of new algorithms and the improvement
of experimental techniques we strongly believe that this will be
achieved in the next few years.
Bottlenecks in Computational Analysis of
PPI Data and Reasons for its Reduced
Impact in pharmacy and Medicine
Computational methodologies for the analysis of PPIs
undoubtedly contributed to the advancement of systems
biology research. In our opinion, however we have reached
the point where research on novel computational methods
has stagnated and further advancements in systems biology
research cannot be achieved solely through the development
of more sophisticated algorithmic solutions. Recently, many
researchers have suggested that advancements in the field of
PPIs research will be facilitated by improved integration of
clinical and molecular data, introducing new clinical phenotype
data, such as the ones coming from integrated data using the
technologies of smart sensors and personalized medicine, in a
format manageable to computational approaches (Tiffin et al.,
2009). The recent advances in other fields of molecular biology,
such as the next generation sequencing data and their analysis,
has enabled the transformation of traditional bioinformatics to
translation bioinformatics. Despite the large availability of works
describing specific combinations of datasets to develop tools
suitable for disease genes prioritization, “our understanding of
how to perform useful predictions using multiple data sources
or across biological networks is still rudimentary” (Nabhan and
Sarkar, 2014), and in particular, to our knowledge, only a few
systematic studies focused on the exploitation of integrated
network methods in medicine applications (Schaefer et al., 2012;
Vinayagam et al., 2014).
For all these reasons, a new approach and more ambitious
objectives should be set for the analysis of PPI data in order
to overcome all these limitations, to meet clinical needs and
cover the lost space in translation bioinformatics analysis which
has been gained by genomics and transcriptomics analysis. The
main challenges for PPI analysis according to our opinion,
except from the already mentioned data integration task and
the linkage of PPI data with clinical data, are the incorporation
of environmental information in the PPI data analysis, the
extended study of PPIs among different organisms, e.g., host–
pathogen interactions, the three dimensional reconstruction of
2D PPI networks for better representation of protein structure,
isoforms and spatial information, the design of new methods for
biomarker discovery using PPI data and the development of new
methods which will facilitate drug discovery using PPI data. In
addition, as firstly proposed by Lopes et al. (2011) and adopted
by Schaefer et al. (2012) and Furlong (2013), the availability of
condition-specific interactomes that are more representative of
the interactions of the proteins in a given tissue or under certain
conditions will improve the significance of such analysis. This
could be done by providing more realistic results, especially for
the exploration of human diseases, where the network topology
properties of proteins encoded by disease genes in interactomes
should be reassessed with spatiotemporal resolution in healthy
and disease states.
Traditional PPI analysis’ approaches study physical and
functional PPIs without taking into account environmental
influences which may strongly affect a PPI or even the formation
of a protein complex. Specifically, it is known that the post
translational modifications of proteins, which play an important
role in enabling them to interact with other proteins, are
significantly affected by environmental changes. Moreover, most
complex diseases are attributed to generalized disturbances in
genetic and proteomic level in cooperation with environmental
causes. In order to exploit PPI analysis in medicine application,
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it should be combined with environmental information and one
way to achieve this is the integration of metabolomics data.
Another field of PPI analysis, which has not yet been
thoroughly explored, is the study of interactions between proteins
from various organisms with a striking example being the
interactions of proteins from host and pathogen organisms which
play a significant role in the viability of the affected cells. Until
recently there existed a lack of large scale efforts to analyze
host–pathogen interactions (Krishnadev and Srinivasan, 2008).
However, these data are now available and a few methods, such
as (Kleftogiannis et al., 2015), for their analysis have already been
published presenting the potential of this field.
One of the most significant new ideas is the one proposed
by Garbutt et al. (2014). This idea refers to the prevalent two
dimensional format of the PPI graphs which is oversimplified and
may lead to loss of information. To take advantage of the dynamic
nature of PPI data, a new three dimensional representation
should be stated integrating protein structure, conformation,
isoforms and spatial information. Several recent research works
take advantage of this idea to incorporate atomic-level protein
structure information in PPI networks (Das et al., 2014) in order
to examine the structural principles of disease mutations over
a PPI network, or even to elucidate the genetic and molecular
mechanisms of underlying human diseases (Wang et al., 2012).
One of the ultimate goals of PPI analysis should be
the biomarkers’ discovery. PPI networks contain significant
information for the cellular mechanisms and functionalities
which should be exploited to uncover disturbances in a
network level. The traditional methods which attempt to
uncover biomarkers from genetic variations or differences in the
expression level have limited applicability as they export a large
number of biomarkers without being able to locate the cause
of the disturbance. When studying diseases in a network level,
the variations are smaller and network based biomarkers are
most likely to represent the cause of the disease. For this reason,
more emphasis should be given to methods for comparing
networks and locating biomarkers from the disturbed proteins,
protein interactions, and protein complexes. Preliminary reports
on methods for biomarkers’ discovery through PPI networks
comparison, revealed a new controversial issue (Wang et al.,
2011). There are some arguing that hubs in PPI networks are
most likely to be found as biomarkers and others arguing against.
This issue should be further studied and clarified in order to
uncover the network metrics which are adequate to be used for
biomarker discovery using PPI graphs.
Another field of PPI analysis which should be further
reinforced is drug discovery through PPI data. PPI data
analysis has a variety of applications in drug discovery so far
(Engin et al., 2014). An interesting idea to reduce the possible
complications of a potential drug is to target proteins which are
interacting with the target protein but have reduced significance
in the overall network topology or even are leafs of the PPI graph.
Even more such ideas are required to be implemented in a novel
way to exploit PPI networks and their topological characteristics
in the drug design process.
In the last 5 years significant initiatives, such as ELIXIR-Data
for Life (Crosswell and Thornton, 2012) and Global Alliance
for Data Sharing (Hayden, 2013), have attempted to promote
biological data sharing, provide the adequate infrastructures
and bring together molecular biologists, bioinformaticians and
clinicians in order to translate life science research mainly
to medicine and bioindustries. These initiatives should be
even more re-enforced and promoted in order to integrate
productively the knowledge and experience of so different fields
toward the realization of personalized medicine. These efforts
will be eased by the expected universal adoption of electronic
medical records standardization and omics translation to clinical
medicine (Issa et al., 2014). However, the full clinical potential
of these initiatives will still remain unexplored until they are
formed in a network perspective that place them within the
systems medicine context. Protein–protein interaction analysis
will by nature play a significant role in this network-perspective
formation.
Conclusions
In this opinion article we have presented our belief about
the future of PPI data analysis emphasizing in presenting
the constraints that delayed the transition from the current
methodologies to a holistic bioinformatics approach, for linking
biological and clinical data. The main constraints that should be
surpassed are the incorporation of environmental information,
the host–pathogen PPI data analysis and the expansion of the
traditional 2D representation of PPI networks with a more
flexible and informative 3D one. These constraints are of equal
importance and most of them should be surpassed in order
to ease the exploitation of PPI analysis in clinical applications.
Moreover, we have stated the most significant areas of clinical
applications of PPI data analysis which are biomarkers and drug
discovery, and we have proposed certain ideas for advancing PPI
analysis in these fields. The next few years, a new boost of clinical
data is expected through the new electronic health records and
data coming from the developing technologies of smart sensors
and personalized medicine (Groves et al., 2013; Yang et al., 2015)
and the computational analysis of PPI data should be ready to
exploit this boost.
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